Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shujun Liu

Showing results (301-310 of 315) with videos related to

Pageof 32
Sort By:
Blood|October 7, 2004
A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemiaJohn C Byrd, Guido Marcucci, Mark R Parthun, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 10, 2009
Modulation of DNA methylation by a sesquiterpene lactone parthenolideZhongfa Liu, Shujun Liu, Zhiliang Xie, et al.
The Journal of Cell Biology|June 8, 2022
SARS-CoV-2 ORF10 impairs cilia by enhancing CUL2ZYG11B activityLiying Wang, Chao Liu, Bo Yang, et al.
Blood|February 13, 2009
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1Ramiro Garzon, Shujun Liu, Muller Fabbri, et al.
The Journal of Clinical Investigation|August 25, 2007
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemiaPaolo Neviani, Ramasamy Santhanam, Joshua J Oaks, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2010
Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabineWilliam Blum, Ramiro Garzon, Rebecca B Klisovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B studySebastian Schwind, Kati Maharry, Michael D Radmacher, et al.
Nature|January 3, 2024
Na<sub>v</sub>1.7 as a chondrocyte regulator and therapeutic target for osteoarthritisWenyu Fu, Dmytro Vasylyev, Yufei Bi, et al.
Cell|March 10, 2010
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blastsAnna M Eiring, Jason G Harb, Paolo Neviani, et al.
Nature Communications|November 9, 2019
Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemiaLiping Dou, Fei Yan, Jiuxia Pang, et al.
Pageof 32

Showing results (301-310 of 315) with videos related to

Sort By:
Pageof 32
Blood|October 7, 2004
A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemiaJohn C Byrd, Guido Marcucci, Mark R Parthun, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 10, 2009
Modulation of DNA methylation by a sesquiterpene lactone parthenolideZhongfa Liu, Shujun Liu, Zhiliang Xie, et al.
The Journal of Cell Biology|June 8, 2022
SARS-CoV-2 ORF10 impairs cilia by enhancing CUL2ZYG11B activityLiying Wang, Chao Liu, Bo Yang, et al.
Blood|February 13, 2009
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1Ramiro Garzon, Shujun Liu, Muller Fabbri, et al.
The Journal of Clinical Investigation|August 25, 2007
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemiaPaolo Neviani, Ramasamy Santhanam, Joshua J Oaks, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2010
Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabineWilliam Blum, Ramiro Garzon, Rebecca B Klisovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B studySebastian Schwind, Kati Maharry, Michael D Radmacher, et al.
Nature|January 3, 2024
Na<sub>v</sub>1.7 as a chondrocyte regulator and therapeutic target for osteoarthritisWenyu Fu, Dmytro Vasylyev, Yufei Bi, et al.
Cell|March 10, 2010
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blastsAnna M Eiring, Jason G Harb, Paolo Neviani, et al.
Nature Communications|November 9, 2019
Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemiaLiping Dou, Fei Yan, Jiuxia Pang, et al.
Pageof 32